Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant 5-FU, Cisplatin, and Radiation for Gastric Cancer
NCT00188266Phase 2Completed
- Sponsor
- University Health Network
- Start
- Aug 2002
- Primary completion
- Dec 2013
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in gastric cancer (GC), sponsored by University Health Network. Started Aug 2002; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00188266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00188266.